Evolution of Advanced Chronic Lymphoid Leukemia Unveiled by Single-Cell Transcriptomics: A Case Report

Frontiers in Oncology
Pavel OstasovIros Barozzi

Abstract

Genetic and transcriptional heterogeneity of Chronic lymphocytic leukaemia (CLL) limits prevention of disease progression. Longitudinal single-cell transcriptomics represents the state-of-the-art method to profile the disease heterogeneity at diagnosis and to inform about disease evolution. Here, we apply single-cell RNA-seq to a CLL case, sampled at diagnosis and relapse, that was treated with FCR (Fludarabine, Cyclophosphamide, Rituximab) and underwent a dramatic decrease in CD19 expression during disease progression. Computational analyses revealed a major switch in clones' dominance during treatment. The clone that expanded at relapse showed 17p and 3p chromosomal deletions, and up-regulation of pathways related to motility, cytokine signaling and antigen presentation. Single-cell RNA-seq uniquely revealed that this clone was already present at low frequency at diagnosis, and it displays feature of plasma cell differentiation, consistent with a more aggressive phenotype. This study shows the benefit of single-cell profiling of CLL heterogeneity at diagnosis, to identify clones that might otherwise not be recognized and to determine the best treatment options.

References

Aug 26, 1998·Journal of Clinical Pathology·L GinaldiD Catovsky
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Dec 10, 2002·Cancer Biotherapy & Radiopharmaceuticals·S SchuhknechtJ Atzpodien
Nov 21, 2007·British Journal of Haematology·Neil CaporasoSusan Slager
Jul 12, 2008·European Journal of Haematology·Louise WatsonDaniel Catovsky
Dec 6, 2012·Experimental Hematology & Oncology·Kemeng WangDelong Liu
May 15, 2013·Leukemia & Lymphoma·Bushra AjazYasser Khaled
Jun 14, 2014·Science·Anoop P PatelBradley E Bernstein
Oct 8, 2014·Advances in Cancer Research·Samit ChatterjeeSridhar Nimmagadda
Mar 31, 2015·Nature Methods·Aaron M NewmanAsh A Alizadeh
Apr 18, 2015·Journal of Hematology & Oncology·Veronica BalattiCarlo M Croce
Jul 21, 2015·Nature Medicine·Andrew J GentlesAsh A Alizadeh
Jul 23, 2015·Nature·Xose S PuenteElías Campo
Oct 16, 2015·Nature·Dan A LandauCatherine J Wu
Jan 20, 2017·Nature Reviews. Disease Primers·Thomas J KippsKanti Rai
Jul 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cameron J TurtleDavid G Maloney
Oct 14, 2018·Annals of Hematology·Valeria BuccheriVanderson Rocha
Jan 31, 2019·Journal for Immunotherapy of Cancer·Cristina BagaceanYves Renaudineau
Mar 21, 2019·Frontiers in Pharmacology·Wei QinHui-Ling Cao
Jun 11, 2019·Cell·Tim StuartRahul Satija
Jul 26, 2019·Genome Research·Luz Garcia-AlonsoJulio Saez-Rodriguez

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE150930

Methods Mentioned

BETA
exome sequencing
flow cytometry
FACS
scRNA-seq

Software Mentioned

PRECOG
GenomicScape
UMAP
InferCNV
CIBERSORT

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.